Discovery of allosteric modulators of factor XIa by targeting hydrophobic domains adjacent to its heparin-binding site

J Med Chem. 2013 Mar 28;56(6):2415-28. doi: 10.1021/jm301757v. Epub 2013 Mar 18.

Abstract

To discover promising sulfated allosteric modulators (SAMs) of glycosaminoglycan-binding proteins (GBPs), such as human factor XIa (FXIa), we screened a library of 26 synthetic, sulfated quinazolin-4(3H)-ones (QAOs) resulting in the identification of six molecules that reduced the Vmax of substrate hydrolysis without influencing the KM. Mutagenesis of residues of the heparin-binding site (HBS) of FXIa introduced a nearly 5-fold loss in inhibition potency supporting recognition of an allosteric site. Fluorescence studies showed a sigmoidal binding profile indicating highly cooperative binding. Competition with a positively charged, heparin-binding polymer did not fully nullify inhibition suggesting importance of hydrophobic forces to binding. This discovery suggests the operation of a dual-element recognition process, which relies on an initial Coulombic attraction of anionic SAMs to the cationic HBS of FXIa that forms a locked complex through tight interaction with an adjacent hydrophobic patch. The dual-element strategy may be widely applicable for discovering SAMs of other GBPs.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Allosteric Regulation / drug effects
  • Biomimetic Materials / pharmacology
  • Catalytic Domain*
  • Drug Discovery*
  • Factor XIa / antagonists & inhibitors
  • Factor XIa / chemistry*
  • Factor XIa / metabolism
  • Glycosaminoglycans / chemistry
  • Heparin / metabolism*
  • Humans
  • Hydrophobic and Hydrophilic Interactions*
  • Protease Inhibitors / chemistry
  • Protease Inhibitors / pharmacology
  • Quinazolinones / chemistry*
  • Quinazolinones / pharmacology*
  • Sulfates / chemistry

Substances

  • Glycosaminoglycans
  • Protease Inhibitors
  • Quinazolinones
  • Sulfates
  • Heparin
  • Factor XIa